Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Neuzner

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
Herzschrittmachertherapie & Elektrophysiologie|December 21, 2010
[A rare cause of syncope in a patient treated with the TASH procedure]C Jabbour, E-M Oenning, J Neuzner, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|December 31, 1998
Implantable cardioverter-defibrillator therapy: influence of left ventricular function on long-term resultsH F Pitschner, J Neuzner, E Himmrich, et al.
The American Journal of Cardiology|January 15, 1997
Clinical predictors of defibrillation energy requirementsJ Neuzner, H Bahawar, A Berkowitsch, et al.
Herzschrittmachertherapie & Elektrophysiologie|June 2, 2009
[Not Available]J Sperzel, T Schwarz, U Poschmann, et al.
Zeitschrift Fur Kardiologie|February 1, 1993
[Cardioverter-defibrillator implantations without thoracotomy: clinical experience with various electrode configurations and defibrillation wave forms of an endocardial/subcutaneous defibrillator system]J Neuzner, C Huth, A Friedl, et al.
Herzschrittmachertherapie & Elektrophysiologie|June 2, 2009
[Not Available]U Poschmann, R M Bohle, J Sperzel, et al.
Pacing and Clinical Electrophysiology : PACE|October 5, 2001
Reduction of pacing output coupling capacitance for sensing the evoked responseJ Sperzel, J Neuzner, T Schwarz, et al.
Herzschrittmachertherapie & Elektrophysiologie|June 2, 2009
[Not Available]B Schulte, J Sperzel, U Poschmann, et al.
Cardiovascular Drugs and Therapy|August 1, 1991
Antiischemic and hemodynamic effects of an oral single dose of 150 mg of the phosphodiesterase inhibitor enoximone in patients with coronary artery disease--relation to plasma concentrationV Mitrovic, O Petrovic, H Bahavar, et al.
Scandinavian Journal of Haematology|May 1, 1985
Lack of efficacy of high-dose intravenous immunoglobulin in autoimmune haemolytic anaemia: a clue to its mechanismC Mueller-Eckhardt, A Salama, I Mahn, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
Herzschrittmachertherapie & Elektrophysiologie|December 21, 2010
[A rare cause of syncope in a patient treated with the TASH procedure]C Jabbour, E-M Oenning, J Neuzner, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|December 31, 1998
Implantable cardioverter-defibrillator therapy: influence of left ventricular function on long-term resultsH F Pitschner, J Neuzner, E Himmrich, et al.
The American Journal of Cardiology|January 15, 1997
Clinical predictors of defibrillation energy requirementsJ Neuzner, H Bahawar, A Berkowitsch, et al.
Herzschrittmachertherapie & Elektrophysiologie|June 2, 2009
[Not Available]J Sperzel, T Schwarz, U Poschmann, et al.
Zeitschrift Fur Kardiologie|February 1, 1993
[Cardioverter-defibrillator implantations without thoracotomy: clinical experience with various electrode configurations and defibrillation wave forms of an endocardial/subcutaneous defibrillator system]J Neuzner, C Huth, A Friedl, et al.
Herzschrittmachertherapie & Elektrophysiologie|June 2, 2009
[Not Available]U Poschmann, R M Bohle, J Sperzel, et al.
Pacing and Clinical Electrophysiology : PACE|October 5, 2001
Reduction of pacing output coupling capacitance for sensing the evoked responseJ Sperzel, J Neuzner, T Schwarz, et al.
Herzschrittmachertherapie & Elektrophysiologie|June 2, 2009
[Not Available]B Schulte, J Sperzel, U Poschmann, et al.
Cardiovascular Drugs and Therapy|August 1, 1991
Antiischemic and hemodynamic effects of an oral single dose of 150 mg of the phosphodiesterase inhibitor enoximone in patients with coronary artery disease--relation to plasma concentrationV Mitrovic, O Petrovic, H Bahavar, et al.
Scandinavian Journal of Haematology|May 1, 1985
Lack of efficacy of high-dose intravenous immunoglobulin in autoimmune haemolytic anaemia: a clue to its mechanismC Mueller-Eckhardt, A Salama, I Mahn, et al.
Pageof 10